George V. Migausky - Aug 20, 2021 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role
Director
Signature
/s/ Pamela Yanchik Connealy, attorney-in-fact for George V. Migausky
Stock symbol
IMVT
Transactions as of
Aug 20, 2021
Transactions value $
$53,550
Form type
4
Date filed
8/20/2021, 06:14 PM
Next filing
Sep 8, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMVT Common Stock Purchase $53.6K +7K +11.63% $7.65 67.2K Aug 20, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.64 - $7.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.